Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease

Conditions:   Venous Thromboembolism;   Venous Thrombosis;   Pulmonary Embolism
Intervention:  
Sponsors:   Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa;   Bayer;   Webmedica
Not yet recruiting - verified August 2016

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: rhEPO;   Drug: Placebo;   Drug: Iron therapy
Sponsor:   GlaxoSmithKline
Not yet recruiting - verified August 2016

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: Darbepoetin alfa;   Drug: Placebo;   Drug: Iron Therapy
Sponsor:   GlaxoSmithKline
Not yet recruiting - verified August 2016

Tranexamic Acid in Revision Total Joint Arthroplasty

Conditions:   Revision Total Knee Arthroplasty;   Revision Total Hip Arthroplasty;   Acute Blood Loss Anemia
Interventions:   Procedure: Revision Total Knee Arthroplasty (TKA);   Procedure: Revision Total Hip Arthroplasty (THA)
Sponsors:   Rush University Medical Center;   Mayo Clinic
Recruiting - verified August 2016

IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Intervention:   Biological: Blood sampling
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified August 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Conditions:   Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions:   Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
Recruiting - verified August 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified August 2016

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified August 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsor:   Bayer
Recruiting - verified August 2016

Mitochondrial-related Platelet Transcript Expression Levels in Pre-diabetic Subjects Randomized to Metformin or Placebo

Condition:   Prediabetes
Interventions:   Drug: Metformin;   Drug: Placebo
Sponsor:   University of Utah
Recruiting - verified August 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified August 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified August 2016

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Conditions:   Chronic Obstructive Pulmonary Disease;   Patients Hospitalized for a COPD Exacerbation
Intervention:   Other: PEP
Sponsor:   University Hospital, Brest
Recruiting - verified August 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016